Paul Camille Mele

This article is a stub. You can help by expanding it.

This article is part of the Tobacco portal on Sourcewatch funded from 2006 - 2009 by the American Legacy Foundation.

Paul Camille Mele, Ph.D. was a former scientist at Philip Morris who assisted behavioral pharmacologist Victor DeNoble in studying nicotine analogues. He has served on the plaintiffs side in lawsuits against the industry.

Biography

Paul Mele, Ph.D., was a scientist in Philip Morris' Behavioral Pharmacology Laboratory in the early 1980s. He testified that he, and other PM employees, studied the addictiveness of nicotine and tried to develop nicotine analogues (alternative forms of nicotine) that also were addictive, but had fewer negative cardiac side effects. Dr. Mele also testified that Philip Morris prohibited him from publishing his findings while he was an employee and tried to stop publication of his findings even after he left the company.

<tdo>resource_id=2727 resource_code=mele_paul_c_phd search_term=Paul Camille Mele</tdo>